All-weather balanced advantage
Dynamic-allocation funds (₹1,000 Cr+) that still beat 11% over three years.
What this screen looks for
- Sub-category is balanced advantage
- 3Y CAGR above 11%
- AUM above ₹1,000 Cr
- Plan is Direct
sub category = balanced advantage AND 3y cagr > 11% AND aum > 1000 AND plan = DirectTop matches by 3Y CAGR
10Aditya Birla Sun Life Balanced Advantage Fund leads this screen at +13.08% 3Y CAGR, ahead of Axis Balanced Advantage Fund at +12.98%.
Every fund matching this screen, ranked by 3Y CAGR. Open a fund for NAV history, rolling returns, risk metrics and peer rank.
| 1 | Aditya Birla Sun Life Balanced Advantage Fund Aditya Birla Sun Life | ★★★★☆ | +8.0% | +13.1% | +11.0% | 0.89% | ₹9,895Cr |
| 2 | Axis Balanced Advantage Fund Axis | ★★★★★ | +4.5% | +13.0% | +10.3% | 1.00% | ₹3,812Cr |
| 3 | Baroda BNP Paribas Balanced Advantage Fund Baroda BNP Paribas | ★★★★☆ | +6.0% | +12.9% | +11.6% | 0.92% | ₹5,204Cr |
| 4 | WhiteOak Capital Balanced Advantage Fund WhiteOak Capital | ★★★★☆ | +4.7% | +12.6% | — | 0.83% | ₹2,274Cr |
| 5 | DSP Dynamic Asset Allocation Fund DSP | ★★★☆☆ | +6.8% | +12.2% | +9.8% | 1.04% | ₹3,792Cr |
| 6 | ICICI Prudential Balanced Advantage Fund ICICI Prudential | ★★★★★ | +6.0% | +12.0% | +11.1% | 1.03% | ₹74,079Cr |
| 7 | Edelweiss Balanced Advantage Fund Edelweiss | ★★★☆☆ | +6.6% | +12.0% | +10.2% | 0.81% | ₹13,230Cr |
| 8 | HDFC Balanced Advantage Fund HDFC | ★★★★☆ | +1.1% | +11.6% | +14.6% | 0.77% | ₹1,06,770Cr |
| 9 | Nippon India Balanced Advantage Fund Nippon India | ★★★☆☆ | +4.4% | +11.5% | +10.3% | 0.89% | ₹9,855Cr |
| 10 | Mirae Asset Balanced Advantage Fund Mirae Asset | ★★★★☆ | +6.0% | +11.4% | — | 0.98% | ₹2,157Cr |
NAV data as of 19 Nov 2026. Direct plans only, one row per fund (Growth option preferred where a scheme has both). ETFs are excluded — they list no Direct plan and need a demat account. Returns are CAGR for periods ≥1 year, computed from AMFI NAV history. Ratings are WealthTicker’s own, ranked within sub-category peers — not a SEBI or agency rating. See our methodology for every formula. This is a screen over public data, not investment advice.